Spatial repellents: The current roadmap to global recommendation of spatial repellents for public health use
Year: 2022
Type: article
Abstract: Spatial repellent (SR) products are envisioned to complement existing vector control methods through the continual release of volatile active ingredients (AI) providing: (i) protection against day-time and early-evening biting; (ii) protection in enclosed/semi-enclosed and peri-domestic spaces; (iii) various formulations to fit context-specific applications; and (iv) increased coverage over traditional control methods. SR product AIs also have demonstrated effect against insecticide-resistant vectors linked to malaria and Aedes-borne virus (ABV) transmission. Over the past two decades, key stakeholders, including World Health Organization (WHO) representatives, have met to discuss the role of SRs in reducing arthropod-borne diseases based on existing evidence. A key focus has been to establish a critical development path for SRs, including scientific, regulatory and social parameters that would constitute an outline for a SR target product profile, i.e. optimum product characteristics. The principal gap is the lack of epidemiological data demonstrating SR public health impact across a range of different ecological and epidemiological settings, to inform a WHO policy recommendation. Here we describe in brief trials that are designed to fulfill evidence needs for WHO assessment and initial projections of SR cost-effectiveness against malaria and dengue.
Institutions: University of Notre Dame, Université des Sciences, des Techniques et des Technologies de Bamako, Malaria Research and Training Center, Catholic Relief Services, Kenya Medical Research Institute, Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Ministry of Health, Nutrition and Indigenous Medicine, Johns Hopkins University, Johns Hopkins Center for Communication Programs, University of California, Davis, University of Washington
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,900
OpenAlex ID: W4310908192
